Ticker: PTIX

Protagenic Therapeutics, Inc. (NASDAQ: PTIX) - Quick company update What's happening: the company completed a reverse-merger/acquisition of Phytanix Bio (effective May 15, 2025), issued preferred and common shares, added five preclinical programs and related IP, raised cash via warrant exercises...